Cadrenal Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CVKD and other ETFs, options, and stocks.About CVKD
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.
CVKD Key Statistics
Stock Snapshot
As of today, Cadrenal Therapeutics(CVKD) shares are valued at $6.88. The company's market cap stands at 18.26M, with a P/E ratio of -0.95.
On 2026-05-06, Cadrenal Therapeutics(CVKD) stock traded between a low of $6.11 and a high of $6.74. Shares are currently priced at $6.88, which is +12.6% above the low and +2.1% below the high.
The Cadrenal Therapeutics(CVKD)'s current trading volume is 103.31K, compared to an average daily volume of 69.28K.
During the past year, Cadrenal Therapeutics(CVKD) stock moved between $4.21 at its lowest and $16.50 at its peak.
During the past year, Cadrenal Therapeutics(CVKD) stock moved between $4.21 at its lowest and $16.50 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.